NBW Capital’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.52M | Sell |
20,221
-211
| -1% | -$26.9K | 0.54% | 60 |
|
|
2025
Q1 | $2.6M | Sell |
20,432
-4,762
| -19% | -$733K | 0.58% | 61 |
|
|
2024
Q4 | $3.63M | Buy |
25,194
+4,152
| +20% | +$595K | 0.67% | 62 |
|
|
2024
Q3 | $3.13M | Sell |
21,042
-15,025
| -42% | -$2.15M | 0.59% | 61 |
|
|
2024
Q2 | $4.55M | Buy |
36,067
+2,451
| +7% | +$384K | 0.9% | 51 |
|
|
2024
Q1 | $6.18M | Buy |
33,616
+578
| +2% | +$110K | 1.26% | 34 |
|
|
2023
Q4 | $5.94M | Buy |
33,038
+2,650
| +9% | +$413K | 1.3% | 30 |
|
|
2023
Q3 | $4.83M | Buy |
30,388
+565
| +2% | +$92.4K | 1.18% | 41 |
|
|
2023
Q2 | $4.22M | Buy |
29,823
+1,692
| +6% | +$271K | 0.98% | 49 |
|
|
2023
Q1 | $4.74M | Buy |
28,131
+8,468
| +43% | +$1.51M | 1.15% | 40 |
|
|
2022
Q4 | $3.33M | Sell |
19,663
-4,861
| -20% | -$882K | 0.85% | 57 |
|
|
2022
Q3 | $4.59M | Buy |
24,524
+4,251
| +21% | +$896K | 1.23% | 34 |
|
|
2022
Q2 | $3.29M | Sell |
20,273
-454
| -2% | -$71.8K | 0.9% | 57 |
|
|
2022
Q1 | $3.9M | Sell |
20,727
-141
| -0.7% | -$26.8K | 0.93% | 53 |
|
|
2021
Q4 | $5.53M | Buy |
20,868
+956
| +5% | +$258K | 1.23% | 38 |
|
|
2021
Q3 | $5.75M | Sell |
19,912
-6,246
| -24% | -$1.6M | 1.39% | 28 |
|
|
2021
Q2 | $5.22M | Buy |
26,158
+794
| +3% | +$154K | 1.27% | 35 |
|
|
2021
Q1 | $4.93M | Buy |
25,364
+5,970
| +31% | +$1.22M | 1.36% | 32 |
|
|
2020
Q4 | $3.72M | Sell |
19,394
-9,697
| -33% | -$1.76M | 1.13% | 39 |
|
|
2020
Q3 | $4.29M | Buy |
29,091
+2,086
| +8% | +$298K | 1.43% | 32 |
|
|
2020
Q2 | $3.34M | Sell |
27,005
-13,389
| -33% | -$1.58M | 1.2% | 36 |
|
|
2020
Q1 | $3.9M | Sell |
40,394
-2,466
| -6% | -$238K | 1.86% | 15 |
|
|
2019
Q4 | $3.96M | Sell |
42,860
-369
| -0.9% | -$31K | 1.13% | 42 |
|
|
2019
Q3 | $3.31M | Buy |
43,229
+7,830
| +22% | +$685K | 0.99% | 47 |
|
|
2019
Q2 | $3.04M | Sell |
35,399
-542
| -2% | -$36.9K | 0.84% | 52 |
|
|
2019
Q1 | $2.12M | Sell |
35,941
-164
| -0.5% | -$9.43K | 0.58% | 61 |
|
|
2018
Q4 | $1.9M | Buy |
36,105
+318
| +0.9% | +$18.6K | 0.68% | 53 |
|
|
2018
Q3 | $1.99M | Sell |
35,787
-12,671
| -26% | -$653K | 0.53% | 65 |
|
|
2018
Q2 | $2.28M | Buy |
48,458
+640
| +1% | +$26.3K | 0.65% | 60 |
|
|
2018
Q1 | $1.73M | Buy |
47,818
+4,373
| +10% | +$154K | 0.54% | 59 |
|
|
2017
Q4 | $1.58M | Sell |
43,445
-371
| -0.8% | -$13.4K | 0.41% | 64 |
|
|
2017
Q3 | $1.68M | Sell |
43,816
-93
| -0.2% | -$3.9K | 0.46% | 62 |
|
|
2017
Q2 | $1.82M | Buy |
43,909
+21,254
| +94% | +$808K | 0.51% | 61 |
|
|
2017
Q1 | $797K | Buy |
22,655
+118
| +0.5% | +$3.74K | 0.22% | 61 |
|
|
2016
Q4 | $695K | Buy |
22,537
+355
| +2% | +$11K | 0.2% | 65 |
|
|
2016
Q3 | $670K | Sell |
22,182
-36
| -0.2% | -$1.09K | 0.19% | 67 |
|
|
2016
Q2 | $608K | Sell |
22,218
-21,797
| -50% | -$557K | 0.19% | 64 |
|
|
2016
Q1 | $1.18M | Sell |
44,015
-990
| -2% | -$24.2K | 0.37% | 60 |
|
|
2015
Q4 | $1.27M | Sell |
45,005
-3,695
| -8% | -$107K | 0.39% | 64 |
|
|
2015
Q3 | $1.36M | Buy |
+48,700
| New | +$1.76M | 0.4% | 70 |
|
Other funds holding RGEN
CIP
NBW Capital's RGEN Position: Q2 2025 in Review
NBW Capital reduced its Repligen (RGEN) stake by 1% in Q2 2025, selling an estimated $26.9K and leaving 20,221 shares worth $2.52M. The position accounts for 0.54% of the portfolio, ranked #60.
NBW Capital first reported a position in RGEN in Q3 2015 and has held it in 40 quarters since. The position peaked at $6.18M in Q1 2024. 444 funds tracked by Wall St. Rank hold RGEN as of Q2 2025.
- NBW Capital held 20,221 shares of Repligen worth $2.52M as of Q2 2025.
- NBW Capital sold 211 Repligen shares in Q2 2025, an estimated $26.9K.
- Repligen made up 0.54% of NBW Capital's portfolio in Q2 2025, its #60 holding.
- NBW Capital first reported a position in Repligen in Q3 2015 and has held it in 40 quarters since.
- NBW Capital's Repligen position peaked at $6.18M in Q1 2024.
- 444 funds tracked by Wall St. Rank held Repligen as of Q2 2025.
Based on NBW Capital's 13F filing for Q2 2025, filed 13 Aug 2025.